Dr. Tsui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Stein Plz
# 1-340
Los Angeles, CA 90095Phone+1 310-825-5000Fax+1 310-794-7906
Summary
- Dr. Edmund Tsui is an ophthalmologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including and Ronald Reagan UCLA Medical Center. He received his medical degree from Geisel School of Medicine at Dartmouth and has been in practice 4 years. He specializes in uveitis, retinal disease, and ocular immunology.
Education & Training
- University of California (San Francisco)Fellowship, Ocular Immunology/Uveitis, 2018 - 2019
- NYU Grossman School of MedicineResidency, Ophthalmology, 2015 - 2018
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Surgery, 2014 - 2015
- Geisel School of Medicine at DartmouthClass of 2014, MD
- The University of Western OntarioBMSc, Physiology, 2006 - 2010
Certifications & Licensure
- CA State Medical License 2018 - 2025
- NH State Medical License 2014 - 2018
- NY State Medical License 2015 - 2018
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 5 citationsThe role of a multicentre data repository in ocular inflammation: The Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS).Sean Ming Sheng Ng, Rebecca Low, Clara Pak, SerSei Lai, Bernett Lee
Eye. 2023-10-01 - 16 citationsEvolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.Rupesh Agrawal, Ilaria Testi, Cecilia S Lee, Edmund Tsui, Marian Blazes
The British Journal of Ophthalmology. 2020-06-25 - 167 citationsThe Current State of Teleophthalmology in the United StatesSiddarth Rathi, Edmund Tsui, Nitish Mehta, Sarwar Zahid, Joel S. Schuman
Ophthalmology. 2017-12-01
Press Mentions
- Recent Advances in the Treatment of Juvenile Idiopathic Arthritis–Associated UveitisFebruary 18th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: